dupilumab
sanofi,regeneron
['dupilumab']
it's great to see this reassuring data on the safety of #dupilumab - long term follow up is needed for all of these novel therapies though! #aad2023 
FRCPC Internal Medicine - Clinical Immunology & Allergy. Lifelong learner, inspired by those around me! Views are my own.⚕️